Administration of CBG000592 (Riboflavin/Vitamin B2) in Patients With Acute Ischemic Stroke

Clinical trial NCT02446977 · COMPLETED

Trial details

NCT number: NCT02446977
Sponsor: Castillo, José, M.D.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ischemic Stroke

Start date: 2015-03-01
Primary completion: 2015-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.